https://australianhealthcareherald.com/article/903569911-the-kcnt1-epilepsy-foundation-and-nord-launch-global-kcnt1-registry Australian Healthcare Herald en PressRelease 2026-04-30T00:00:00+00:00 The KCNT1 Epilepsy Foundation and NORD® Launch Global KCNT1 Registry https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24055269-logo-of-the-kcnt1-epilepsy-foun-1200x628.png https://australianhealthcareherald.com/article/909197138-mesoblast-reports-ryoncil-net-revenues-of-us-30-3m-and-improved-net-operating-cash-spend-for-the-quarter-to-us-4-1-million Australian Healthcare Herald en PressRelease 2026-04-30T00:55:01+00:00 Mesoblast Reports Ryoncil® Net Revenues of US$30.3m and Improved Net Operating Cash Spend for the Quarter to US$4.1 Million https://ml.globenewswire.com/media/a9938a8a-a0ba-4708-abd5-2219515343fc/small/mesologo-png.png https://australianhealthcareherald.com/article/909141493-optimal-psma-trial-of-tlx597-tx-next-generation-rlt-presented-at-ipcs-2026-highlighting-therapeutic-potential-in-prostate-cancer Australian Healthcare Herald en PressRelease 2026-04-29T21:00:00+00:00 OPTIMAL-PSMA Trial of TLX597-Tx Next Generation RLT Presented at IPCS 2026 Highlighting Therapeutic Potential in Prostate Cancer https://ml.globenewswire.com/media/77ceffdf-31cc-415f-9747-efee950af329/small/telix-main-logo-3-png.png https://australianhealthcareherald.com/article/908935134-cleaning-edge-invests-millions-in-cesgo-platform-to-transform-cleaning-transparency-and-accountability Australian Healthcare Herald en PressRelease 2026-04-29T05:25:24+00:00 Cleaning Edge invests millions in CESgo platform to transform cleaning transparency and accountability https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24843336-clay-2-800x571.jpeg https://australianhealthcareherald.com/article/908623915-new-book-your-aging-advantage-reframes-aging-as-opportunity-not-decline Australian Healthcare Herald en PressRelease 2026-04-28T21:00:08+00:00 New Book Your Aging Advantage Reframes Aging as Opportunity, Not Decline https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24842285-yaa-book-cover-1645x2555.jpeg https://australianhealthcareherald.com/article/908889529-mesoblast-achieves-patient-recruitment-target-in-pivotal-phase-3-trial-for-chronic-low-back-pain Australian Healthcare Herald en PressRelease 2026-04-29T00:53:16+00:00 Mesoblast Achieves Patient Recruitment Target in Pivotal Phase 3 Trial for Chronic Low Back Pain https://ml.globenewswire.com/media/a9938a8a-a0ba-4708-abd5-2219515343fc/small/mesologo-png.png https://australianhealthcareherald.com/article/907752484-flexagon-announces-general-availability-of-complete-change-control-platform-for-enterprise-applications Australian Healthcare Herald en PressRelease 2026-04-28T12:00:00+00:00 Flexagon Announces General Availability of Complete Change Control Platform for Enterprise Applications https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24840660-flexagon-ombre-1200x675.jpeg https://australianhealthcareherald.com/article/908639370-celebrace-introduces-first-fully-integrated-ai-driven-custom-metal-braces-system Australian Healthcare Herald en PressRelease 2026-04-28T05:19:03+00:00 Celebrace Introduces First Fully Integrated AI-Driven Custom Metal Braces System https://australianhealthcareherald.com/article/908700454-anteris-technologies-secures-cms-reimbursement-supporting-u-s-site-activation-for-paradigm-trial Australian Healthcare Herald en PressRelease 2026-04-28T10:00:00+00:00 Anteris Technologies Secures CMS Reimbursement Supporting U.S. Site Activation for PARADIGM Trial https://ml.globenewswire.com/media/90a5ae8d-7cf0-4a3d-b38c-f4ad7e3fbf0e/small/anteris-tech-rgb-blue-png.png